Trial
NCT03444649
Epacadostat, Idarubicin and Cytarabine (EIC) in AML
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
—
Condition
AML
Intervention
Epacadostat
Why stopped
IMP will not be further developed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-11